Eearly loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries

Abstract

Early patient losses were increasingly common when programmes were scaled up and were associated with a fee for service and advanced immunodeficiency at baseline. Measures to maximize ART programme retention are required in resource-poor countries.